159 related articles for article (PubMed ID: 36371643)
1. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review.
Kitschen A; Aleknonytė-Resch M; Sakalytė G; Diederich F
Eur J Neurol; 2023 Mar; 30(3):749-761. PubMed ID: 36371643
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of epilepsy surgery in children and adolescents with drug resistant focal epilepsy at three years in a tertiary care epilepsy center in Thailand.
Anurat K; Khongkhatithum C; Pattanaprateep O; Chamroonrat W; Boongird A; Visudtibhan A; Thampratankul L
J Clin Neurosci; 2020 Sep; 79():163-168. PubMed ID: 33070889
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.
Elliott J; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Syst Rev; 2019 Mar; 8(1):75. PubMed ID: 30917869
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review of Cost-Effectiveness Analysis for Surgical and Neurostimulation Treatments for Drug-Resistant Epilepsy in Adults.
Ngan Kee N; Foster E; Marquina C; Tan A; Pang SST; O'Brien TJ; Kwan P; Jackson GD; Chen Z; Ademi Z
Neurology; 2023 May; 100(18):e1866-e1877. PubMed ID: 36927880
[TBL] [Abstract][Full Text] [Related]
7. Cost-of-illness and Economic Evaluation of Interventions in Children and Adolescents With Chronic Pain: A Systematic Review.
Kitschen A; Wahidie D; Meyer D; Rau LM; Ruhe AK; Wager J; Zernikow B; Sauerland D
Clin J Pain; 2024 May; 40(5):306-319. PubMed ID: 38268231
[TBL] [Abstract][Full Text] [Related]
8. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
11. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
12. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of responsive neurostimulation for drug-resistant focal onset epilepsy.
Youngerman BE; Mahajan UV; Dyster TG; Srinivasan S; Halpern CH; McKhann GM; Sheth SA
Epilepsia; 2021 Nov; 62(11):2804-2813. PubMed ID: 34458986
[TBL] [Abstract][Full Text] [Related]
15. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy.
Widjaja E; Li B; Schinkel CD; Puchalski Ritchie L; Weaver J; Snead OC; Rutka JT; Coyte PC
Epilepsy Res; 2011 Mar; 94(1-2):61-8. PubMed ID: 21306874
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: A 5-year follow-up study.
Picot MC; Jaussent A; Neveu D; Kahane P; Crespel A; Gelisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Macioce V; Dujols P; Ryvlin P
Epilepsia; 2016 Oct; 57(10):1669-1679. PubMed ID: 27595433
[TBL] [Abstract][Full Text] [Related]
20. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
Hartwell D; Jones J; Baxter L; Shepherd J
Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
